Piñeiro-Llanes J, Suzuki-Hatano S, Jain A, Venigalla S, Kamat M, Basso KB, Cade WT, Simmons CS, Pacak CA. Rescue of mitochondrial dysfunction through alteration of extracellular matrix composition in barth syndrome cardiac fibroblasts. Biomaterials. 2025 Apr;315:122922. doi: 10.1016/j.biomaterials.2024.122922. Epub 2024 Oct 26. PubMed PMID: 39509858; PubMed Central PMCID: PMC11625619.
Chauhan M, Daugherty AL, Khadir FE, Duzenli OF, Hoffman A, Tinklenberg JA, Kang PB, Aslanidi G, Pacak CA. AAV-DJ is superior to AAV9 for targeting brain and spinal cord, and de-targeting liver across multiple delivery routes in mice. J Transl Med. 2024 Sep 5;22(1):824. doi: 10.1186/s12967-024-05599-5. PubMed PMID: 39237935; PubMed Central PMCID: PMC11375878.
Pacak CA, Suzuki-Hatano S, Khadir F, Daugherty AL, Sriramvenugopal M, Gosiker BJ, Kang PB, Cade WT. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle. J Transl Med. 2023 Oct 24;21(1):748. doi: 10.1186/s12967-023-04626-1. PubMed PMID: 37875924; PubMed Central PMCID: PMC10598899.
Maguina M, Kang PB, Tsai AC, Pacak CA. Peripheral neuropathies associated with DNA repair disorders. Muscle Nerve. 2023 Feb;67(2):101-110. doi: 10.1002/mus.27721. Epub 2022 Oct 3. Review. PubMed PMID: 36190439; PubMed Central PMCID: PMC10075233.
Piñeiro-Llanes J, Suzuki-Hatano S, Jain A, Pérez Medina VA, Cade WT, Pacak CA, Simmons CS. Matrix produced by diseased cardiac fibroblasts affects early myotube formation and function. Acta Biomater. 2022 Oct 15;152:100-112. doi: 10.1016/j.actbio.2022.08.060. Epub 2022 Aug 31. PubMed PMID: 36055608; PubMed Central PMCID: PMC10625442.